Treatment-related adverse events of antibody-drug conjugates in clinical trials: A systematic review and meta-analysis.
Jinming LiGuoshuang ShenZhen LiuYaobang LiuMiaozhou WangFuxing ZhaoDengfeng RenQiqi XieZitao LiZhilin LiuYi ZhaoZongbi YiXinlan LiuZhengbo XuJiuda ZhaoPublished in: Cancer innovation (2023)
This study provides a comprehensive overview of AEs related to ADCs used for cancer treatment. ADC use resulted in a high incidence of any-grade AEs but a low incidence of grade ≥ 3 AEs. The AE profiles and incidence differed according to cancer type, ADC type, and ADC components.